Feasibility and safety of an automated chyme reinfusion device for high‐output stomas and enterocutaneous fistulas in hospitalized adults: A descriptive cohort study
Journal of Parenteral and Enteral Nutrition · 15.11.2026
DOI: 10.1002/jpen.70165 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Parenteral and Enteral Nutrition, online erschienen am 15.11.2026. Verfasst von Manuel Boros und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Digestive Surgery, University Hospitals of Geneva, Genève, Switzerland. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
High‐output stomas and enterocutaneous fistulas cause dehydration, electrolyte disturbances, malnutrition, and prolonged dependence on parenteral nutrition. Chyme reinfusion may restore distal enteral continuity but remains technically demanding. Our descriptive cohort study evaluated the technical feasibility of chyme reinfusion using an automated chyme reinfusion device in adults with high‐output stomas or enterocutaneous fistulas.
Methods
We included consecutive hospitalized postoperative adults who initiated an automated chyme reinfusion device for a high‐output stoma or enterocutaneous fistula at Geneva University Hospitals between 2022 and 2025. The primary outcome was technical feasibility, defined as successful use of the device without premature discontinuation due to device‐related failure. Secondary outcomes were tolerance, device‐related complications, changes in parenteral nutrition requirements, and body weight and serum albumin at baseline and Week 4.
Results
Twelve patients were included. Technical feasibility was achieved in 10 (83.3%). Chyme reinfusion was initiated a median of 37 days after surgery and maintained for a median of 42 days. Among 10 patients receiving parenteral nutrition at baseline, it was discontinued in three and reduced in three. Median body weight was 61.7 kg at baseline and 64.6 kg at Week 4. Median serum albumin was 25 and 29.5 g/L, respectively. Reinfusion‐related difficulties occurred in nine patients. Two catheter migrations occurred, one causing small‐bowel perforation requiring resection.
Conclusion
Automated chyme reinfusion appears technically feasible in selected patients with high‐output stomas or enterocutaneous fistulas, but practical difficulties and device‐related complications are common. Prospective studies are needed to define patient selection, safety, and clinical benefit.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Digestive Surgery, University Hospitals of Geneva, Genève, Switzerland.
- Medical School, University of Geneva, Geneva, Switzerland.
- Department of Digestive and Surgical Oncology, Institut Paoli-Calmettes, Marseille, France.
ORCID-Profile: Jacques-Emmanuel Saadoun, Eleftherios Gialamas, Alexandre Balaphas, Christian Toso
Zitieren
APA
Boros, M., Saadoun, J. E., Gialamas, E., Balaphas, A., Toso, C., Meyer, J., Liot, E., Meurette, G., & Ris, F. (2026). Feasibility and safety of an automated chyme reinfusion device for high‐output stomas and enterocutaneous fistulas in hospitalized adults: A descriptive cohort study. Journal of Parenteral and Enteral Nutrition. https://doi.org/10.1002/jpen.70165
Vancouver
Boros M, Saadoun JE, Gialamas E, Balaphas A, Toso C, Meyer J, et al. Feasibility and safety of an automated chyme reinfusion device for high‐output stomas and enterocutaneous fistulas in hospitalized adults: A descriptive cohort study. Journal of Parenteral and Enteral Nutrition. 2026. doi:10.1002/jpen.70165
BibTeX
@article{Boros2026,
author = {Boros, Manuel and Saadoun, Jacques-Emmanuel and Gialamas, Eleftherios and Balaphas, Alexandre and Toso, Christian and Meyer, Jérémy and Liot, Emilie and Meurette, Guillaume and Ris, Frédéric},
title = {Feasibility and safety of an automated chyme reinfusion device for high‐output stomas and enterocutaneous fistulas in hospitalized adults: A descriptive cohort study},
journal = {Journal of Parenteral and Enteral Nutrition},
year = {2026},
doi = {10.1002/jpen.70165}
}
EUVIMED